DKNG insider exercises options and executes 10b5-1 sales, retains 500,000 shares
Rhea-AI Filing Summary
DraftKings insider activity by Chief Legal Officer Dodge R Stanton on 08/05/2025: Mr. Stanton exercised stock options to acquire 66,382 shares at an exercise price of $3.29 and 38,718 shares at $2.95. He sold 104,507 shares at a weighted average price of $44.60 (sales ranged $44.00–$44.97) and 1,047 shares at a weighted average price of $45.06 (sales ranged $45.03–$45.13) under a Rule 10b5-1 plan adopted December 13, 2024.
After these transactions the reporting person beneficially owned 500,000 shares of Class A common stock. The exercised options were granted on April 18, 2018 and November 7, 2017, and footnotes state remaining options had vested. The Form 4 was signed by an attorney-in-fact on 08/07/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR Insider exercised vested options and sold about 105,554 shares under a pre-arranged 10b5-1 plan, retaining 500,000 shares.
The exercise of in-the-money options at low exercise prices ($3.29 and $2.95) converted option holdings into Class A shares while a pre-established Rule 10b5-1 plan executed sales of 104,507 and 1,047 shares at weighted averages near $44.60 and $45.06 respectively. These transactions are routine compensation-related exercises and systematic divestitures; the filing does not disclose any company financial metrics or material corporate events that would change an investment thesis.
TL;DR Transactions appear compliant and documented under Rule 10b5-1; exercised options were vested and sales were pre-arranged.
The Form 4 documents option exercises from grants dated 2017 and 2018 and sale activity pursuant to a 10b5-1 program adopted December 13, 2024. Footnotes explicitly disclose weighted average sale price ranges and offer to provide transaction-level details on request, which supports procedural transparency. No departures from standard disclosure practices are evident in the filing.